KURA Kura Oncology Inc

Kura Oncology Inc is a clinical stage biopharmaceutical company, engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers.

$13.97  +0.03 (0.22%)
As of 11/30/2021 15:59:58 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  09/16/2015
Outstanding shares:  66,555,775
Average volume:  917,183
Market cap:   $932,113,629
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    50127T109
ISIN:        US50127T1097
Sedol:      BYZD465
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   1.74
PS ratio:   0.00
Return on equity:   -23.21%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy